TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • May 12th, 2016 • Carbylan Therapeutics, Inc. • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) by and between David M. Gravett (“Executive”) and Carbylan Therapeutics, Inc. (the “Company”) is made effective eight (8) days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Agreement as provided in Section 6(c) below. Any reference to the Company throughout this Agreement shall include the Company, its subsidiaries and any successors thereto.
SEPARATION AGREEMENTSeparation Agreement • May 12th, 2016 • Carbylan Therapeutics, Inc. • Pharmaceutical preparations • California
This Separation Agreement (the “Agreement”) by and between Dr. Premchandran Ramiya, Ph.D., (“Executive”) and Carbylan Therapeutics, Inc. (the “Company”) is made effective eight (8) days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Agreement as provided in Section 5(c) below. Any reference to the Company throughout this Agreement shall include the Company, its subsidiaries and any successors thereto.
